Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Eye on Ocular HealthTime to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Outcomes for PDR Patients LTFU for at Least 1 Year
OphthalmologyOutcomes for PDR Patients LTFU for at Least 1 Year
Examining Therapeutic Timing in RVO-Related Macular Edema
Eye on Ocular HealthExamining Therapeutic Timing in RVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
OphthalmologyReal-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular HealthHow Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
- advertisement
Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
CME/CE Virtual EventEnhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
February 26, 2026
07:30 PM - 08:30 PM ET
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEOvercoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEPatient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEA Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEIt Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
- advertisement
Managing Eye-Related Adverse Events Caused by Cancer Treatments
Medical Industry FeatureManaging Eye-Related Adverse Events Caused by Cancer Treatments
MIRASOL Insights in PROC: A Biomarker-Driven Approach
Project Oncology®MIRASOL Insights in PROC: A Biomarker-Driven Approach
The Importance of Diagnosing Dry Eye Disease Early
Medical Industry FeatureThe Importance of Diagnosing Dry Eye Disease Early
Inhibiting Inflammation in Dry Eye Disease
Medical Industry FeatureInhibiting Inflammation in Dry Eye Disease
Exploring Perspectives on Speed of Onset for Dry Eye Treatment
Medical Industry FeatureExploring Perspectives on Speed of Onset for Dry Eye Treatment
- 02/19/2026
- 02/16/2026
- 02/16/2026
- 02/12/2026
- 02/11/2026
- 02/10/2026